- Home
- HEPA vs XPON Comparison
HEPA vs XPON Comparison
Compare HEPA & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- XPON
- Stock Information
- Founded
- HEPA 2013
- XPON 2016
- Country
- HEPA United States
- XPON United States
- Employees
- HEPA N/A
- XPON N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- XPON Electronic Components
- Sector
- HEPA Health Care
- XPON Technology
- Exchange
- HEPA Nasdaq
- XPON Nasdaq
- Market Cap
- HEPA 1.7M
- XPON 1.9M
- IPO Year
- HEPA N/A
- XPON 2022
- Fundamental
- Price
- HEPA $0.17
- XPON $1.44
- Analyst Decision
- HEPA
- XPON
- Analyst Count
- HEPA 0
- XPON 0
- Target Price
- HEPA N/A
- XPON N/A
- AVG Volume (30 Days)
- HEPA 31.4M
- XPON 101.8K
- Earning Date
- HEPA 04-15-2025
- XPON 03-27-2025
- Dividend Yield
- HEPA N/A
- XPON N/A
- EPS Growth
- HEPA N/A
- XPON N/A
- EPS
- HEPA N/A
- XPON N/A
- Revenue
- HEPA N/A
- XPON $4,498,181.00
- Revenue This Year
- HEPA N/A
- XPON N/A
- Revenue Next Year
- HEPA N/A
- XPON $66.62
- P/E Ratio
- HEPA N/A
- XPON N/A
- Revenue Growth
- HEPA N/A
- XPON N/A
- 52 Week Low
- HEPA $0.12
- XPON $1.32
- 52 Week High
- HEPA $3.33
- XPON $418.00
- Technical
- Relative Strength Index (RSI)
- HEPA 36.41
- XPON 41.61
- Support Level
- HEPA $0.17
- XPON $1.33
- Resistance Level
- HEPA $0.19
- XPON $1.53
- Average True Range (ATR)
- HEPA 0.02
- XPON 0.08
- MACD
- HEPA 0.01
- XPON 0.03
- Stochastic Oscillator
- HEPA 28.55
- XPON 57.97
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.